PSCR (Proto Script Pharmaceutical) LT-Debt-to-Total-Asset: 0.00 (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical LT-Debt-to-Total-Asset?

Proto Script Pharmaceutical PSCR LT-Debt-to-Total-Asset is 0.00 as of Sep. 2017.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Proto Script Pharmaceutical's long-term debt to total assests ratio for the quarter that ended in Sep. 2017 was 0.00.

Proto Script Pharmaceutical's long-term debt to total assets ratio stayed the same from Sep. 2016 (0.00) to Sep. 2017 (0.00).

Proto Script Pharmaceutical  (OTCPK:PSCR) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Proto Script Pharmaceutical LT-Debt-to-Total-Asset Related Terms

Proto Script Pharmaceutical LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical LT-Debt-to-Total-Asset Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
LT-Debt-to-Total-Asset
0.00 0.00 0.00 0.00 0.00

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Proto Script Pharmaceutical LT-Debt-to-Total-Asset Calculation

Proto Script Pharmaceutical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in May. 2016 is calculated as

LT Debt to Total Assets (A: May. 2016 )=Long-Term Debt & Capital Lease Obligation (A: May. 2016 )/Total Assets (A: May. 2016 )
=0/0.012
=

Proto Script Pharmaceutical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2017 is calculated as

LT Debt to Total Assets (Q: Sep. 2017 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2017 )/Total Assets (Q: Sep. 2017 )
=0/0.235
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Proto Script Pharmaceutical (PSCR) has a LT-Debt-to-Total-Asset of 0.00 as of Sep. 2017. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's LT-Debt-to-Total-Asset too high?
Proto Script Pharmaceutical's current LT-Debt-to-Total-Asset is 0.00.
How does Proto Script Pharmaceutical's LT-Debt-to-Total-Asset compare to EXCC and NXES?
Proto Script Pharmaceutical's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Business Services company?
A good LT-Debt-to-Total-Asset depends on the Business Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Proto Script Pharmaceutical and its competitors. Proto Script Pharmaceutical's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current LT-Debt-to-Total-Asset is 0.00 as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.